Discover More:
Public Health advocates call on policymakers to end drug shortages in the U.S. ...
Drug shortages pose a significant, ongoing threat to our healthcare system and to the patients who rely on medicine for their wellbeing and survival.
Q&A with Mrunal Jaywant: How the Discovery of Nitrosamines in Medicines Shifted the P...
In April, the World Health Organization (WHO) became the latest health authority to release a draft guidance on Current Good Manufacturing Practices (CGMP) considerations for the prevention and management of nitrosamine contamination in pharmaceutical products.
Quality is a foundation for global vaccine preparedness...
The emergence of COVID-19 almost five years ago forced us all to face the realities of containing and mitigating a highly transmissible, deadly pandemic.
Building Bridges: How Collaboration is Propelling India's Pharma Industry Forward ...
It’s been nearly 20 years since the US Pharmacopeia (USP) established our laboratories in Hyderabad and we began growing our team of scientists and other professionals in India. In the time since, the global pharmaceutical landscape has undergone a tremendous amount of evolution.